epsilon-Amino-caproic acid in the management of acute promyelocytic leukaemia.
In three cases of acute promyelocytic leukaemia remission was induced with cytosine arabinoside, daunarubicin and vincristine. The coagulopathy was controlled by EACA without resorting to the use of heparin. All three survived more than 85 weeks.
D000328:Adult; D000614:Aminocaproates / Q000627:therapeutic use*; D015119:Aminocaproic Acid / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D014750:Vincristine / Q000627:therapeutic use
D000614:Aminocaproates; D003561:Cytarabine; D014750:Vincristine; D015119:Aminocaproic Acid; D003630:Daunorubicin